These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 818884)

  • 21. [Vasodilatation as a therapeutic principle in the treatment of angina pectoris and recent heart infarct].
    Behrenbeck DW; Tauchert M; Hötzel J; Jansen W; Niehues B; Hilger HH
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():203-6. PubMed ID: 417501
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect on the peripheral circulation during treatment of cardiac insufficiency].
    Mukharliamov NM
    Kardiologiia; 1980 Apr; 20(4):9-14. PubMed ID: 6768919
    [No Abstract]   [Full Text] [Related]  

  • 23. [Organic nitrate and vasodilator therapy of cardiac insufficiency].
    Strauer BE
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():154-70. PubMed ID: 417497
    [No Abstract]   [Full Text] [Related]  

  • 24. Vasodilators in acute circulatory failure.
    Blakeley C; Tinker J
    Intensive Care Med; 1983; 9(1):5-11. PubMed ID: 6403603
    [No Abstract]   [Full Text] [Related]  

  • 25. [Drug treatment of chronic coronary disease].
    Halawa B
    Wiad Lek; 1980 Jan; 33(2):107-11. PubMed ID: 6768197
    [No Abstract]   [Full Text] [Related]  

  • 26. Vasodilators in heart failure secondary to coronary artery disease.
    Parmley WW; Rouleau JL; Chatterjee K
    Am Heart J; 1982 Apr; 103(4 Pt 2):625-32. PubMed ID: 7064804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure.
    Mason DT
    Am J Med; 1978 Jul; 65(1):106-25. PubMed ID: 99030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Vasodilators, oral nitrate derivatives and treatment of heart failure].
    Chiche P; Baligadoo S
    Coeur Med Interne; 1976; 15(2):139-46. PubMed ID: 825345
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of ouabain on coronary and systemic vascular resistance and myocardial oxygen consumption in patients without heart failure.
    DeMots H; Rahimtoola SH; McAnulty JH; Porter GA
    Am J Cardiol; 1978 Jan; 41(1):88-93. PubMed ID: 623010
    [No Abstract]   [Full Text] [Related]  

  • 30. Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside.
    Pierpont GL; Cohn JN; Franciosa JA
    Chest; 1978 Jan; 73(1):8-13. PubMed ID: 620563
    [No Abstract]   [Full Text] [Related]  

  • 31. Vasodilator therapy for chronic left ventricular failure.
    Kovick RB; Tillisch JH; Berens SC; Bramowitz AD; Shine KI
    Circulation; 1976 Feb; 53(2):322-8. PubMed ID: 812614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical trial of the new coronary dilator hexobendine].
    Henke C; Dudik E; Steim H
    Arzneimittelforschung; 1968 Aug; 18(8):1103-7. PubMed ID: 4885101
    [No Abstract]   [Full Text] [Related]  

  • 33. [Area of the ischemic lesion in acute myocardial infarct: critical review of the use of vasodilator agents].
    Permutti B; Costa PP; Fernandes P; Locatelli C
    Boll Soc Ital Cardiol; 1980; 25(7):803-5. PubMed ID: 7272077
    [No Abstract]   [Full Text] [Related]  

  • 34. Prevention and reversal of myocardial failure in endotoxin shock.
    Hinshaw LB; Archer LT; Black MR; Greenfield LJ; Guenter CA
    Surg Gynecol Obstet; 1973 Jan; 136(1):1-11. PubMed ID: 4565872
    [No Abstract]   [Full Text] [Related]  

  • 35. Nitrates in heart failure. Pathophysiological mechanisms and therapeutic applications.
    Timmis AD; Richardson PJ
    Scand J Clin Lab Invest Suppl; 1984; 173():59-64. PubMed ID: 6442003
    [No Abstract]   [Full Text] [Related]  

  • 36. Vasodilator therapy of pump failure complicating acute myocardial infarction.
    Massie BM; Chatterjee K
    Med Clin North Am; 1979 Jan; 63(1):25-51. PubMed ID: 107378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Vasodilator agents in the treatment of heart failure].
    Prati PL; Manfrin M
    G Ital Cardiol; 1978; 8(1):1-11. PubMed ID: 415927
    [No Abstract]   [Full Text] [Related]  

  • 38. Myocardial circulatory and metabolic effects of atrial natriuretic peptide after coronary artery bypass grafting.
    Valsson F; Lundin S; Kirnö K; Hedner T; Saito Y; Ricksten SE
    Anesth Analg; 1996 Nov; 83(5):928-34. PubMed ID: 8895265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of cardiac insufficiency with vasodilators].
    Salazar Dávila E
    Cardiology; 1980; 66 Suppl 2():146-53. PubMed ID: 7285025
    [No Abstract]   [Full Text] [Related]  

  • 40. The use of vasodilator agents in the treatment of heart failure.
    Lloyd EA
    S Afr Med J; 1979 Nov; 56(20):787-95. PubMed ID: 159502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.